¼¼°èÀÇ Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀå
Hemocytometers
»óǰÄÚµå : 1533698
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 374 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,101,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,303,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ç÷±¸ °è¼ö ÀåÄ¡ÀÇ ½ÃÀåÀº 2030³â±îÁö 29¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 15¾ï ´Þ·¯·Î ÃßÁ¤µÈ Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.2%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç 2030³â¿¡´Â 29¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Àç»ç¿ë °¡´ÉÇÑ Ç÷±¸ °è¼ö ÀåÄ¡´Â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.5%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, ºÐ¼® ±â°£ Á¾·á±îÁö 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÏȸ¿ë Ç÷±¸ °è¼ö ÀåÄ¡ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 2,160¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 12.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ÀÇ Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀåÀº 2023³â 4¾ï 2,160¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï130¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç ºÐ¼® ±â°£ 2023-2030³â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº 12.7%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 6.8%¿Í 7.9%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀå : ÁÖ¿ä ÃËÁø¿äÀΰú µ¿Çâ ¿ä¾à

Ç÷±¸ °è¼ö ÀåÄ¡´Â ¾×ü »ùÇÿ¡¼­ Ç÷¾× ¼¼Æ÷ ¹× ±âŸ À¯ÇüÀÇ ¼¼Æ÷¸¦ °è»êÇÏ´Â µ¥ »ç¿ëµÇ´Â Á¤¹Ð ÀåºñÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î ÀÌ·¯ÇÑ ÀåÄ¡´Â Á¤È®ÇÏ°Ô ¿¡ÄªµÈ ±×¸®µå ¼±ÀÌ ÀÖ´Â µÎ²¨¿î À¯¸® Çö¹Ì°æ ½½¶óÀ̵å·Î ±¸¼ºµË´Ï´Ù. »ùÇÃÀ» Ç÷±¸ °è¼ö ÀåÄ¡¿¡ ³ÖÀ¸¸éÀÌ ±×¸®µå¸¦ »ç¿ëÇÏ¿© Çö¹Ì°æÀ¸·Î ¼¼Æ÷¸¦ Á¤È®ÇÏ°Ô °è»êÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç÷±¸ °è¼ö ÀåÄ¡´Â ÀÓ»ó Áø´Ü, ½ÇÇè½Ç ¹× »ý¸í °øÇÐÀÇ ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Ç÷¾×, ¼Òº¯ ¹× ±âŸ »ý¹°ÇÐÀû À¯Ã¼ÀÇ ¼¼Æ÷ ³óµµ¸¦ Á¤·®È­ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¼¼Æ÷¸¦ Á¤È®ÇÏ°Ô °è»êÇÏ´Â °ÍÀº Áúº´ Áø´Ü, ¸ð´ÏÅ͸µ, ¿¬±¸ ¹× ÀǾàǰ °³¹ß¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀåÀº ±â¼úÀÇ Áøº¸¿Í ´Ù¾çÇÑ °úÇÐ,ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ ¿ëµµ Áõ°¡¿¡ ÀÇÇØ Å©°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÃÖ½ÅÀÇ Ç÷±¸ °è¼ö ÀåÄ¡´Â ±×¸®µå µðÀÚÀÎÀÇ °³¼±À̳ª ³»±¸¼ºÀÌ ÀÖ´Â °íǰÁú ¼ÒÀçÀÇ »ç¿ë µî, Á¤¹Ðµµ¿Í »ç¿ëÀÇ ¿ëÀ̼ºÀ» Çâ»ó½ÃŰ´Â ±â´ÉÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ Ç÷±¸ °è¼ö±â¿Í ÀÚµ¿ ¼¿ Ä«¿îÅͰ¡ µîÀåÇÏ¿© º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ ÃøÁ¤ÀÌ °¡´ÉÇØÁ® ÀÎÀ§Àû ½Ç¼ö¸¦ ÁÙÀÌ°í ½ÇÇè½ÇÀÇ È¿À²À» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Ç÷±¸ °è¼ö ÀåÄ¡ÀÇ ÀÀ¿ë ¹üÀ§¸¦ ³ÐÈ÷°í Ç÷¾×ÇÐ, Á¾¾çÇÐ, ¹Ì»ý¹°ÇÐ, ¼¼Æ÷ »ý¹°ÇÐ ¿¬±¸¿¡ ÇʼöÀûÀÎ µµ±¸°¡µÇ¾ú½À´Ï´Ù. °Ô´Ù°¡, Ç÷±¸ °è¼ö ÀåÄ¡¿Í ´Ù¸¥ Áø´Ü Àåºñ ¹× ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ ÅëÇÕÀº ¼¼Æ÷ °è¼ö ÇÁ·Î¼¼½º¿Í µ¥ÀÌÅÍ °ü¸®¸¦ ´õ¿í °£¼ÒÈ­Çß½À´Ï´Ù.

Ç÷±¸ °è¼ö ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ¾ß±âµË´Ï´Ù. ù°, ¾ÏÀ̳ª °¨¿° µî Á¤±âÀûÀÎ Ç÷±¸ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ Áúº´ÀÇ À¯º´·ü Áõ°¡°¡ Ç÷±¸ °è¼ö ÀåÄ¡ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. µÑ°, »ý¸í°øÇаú »ý¸í°úÇÐÀÇ ¿¬±¸°³¹ß Ȱµ¿ È®´ë´Â Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼¼Æ÷ °è¼ö µµ±¸ÀÇ Çʿ伺¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ ±â¼ú°ú ÀÚµ¿È­ ±â¼úÀÇ ¹ßÀüÀº ¶ÇÇÑ ¼¼Æ÷ °è¼öÀÇ Á¤È®¼º°ú ¼Óµµ¸¦ Çâ»ó½Ã۱â À§ÇØ ½ÃÀå ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °Ô´Ù°¡, °³ÀÎÈ­µÈ ÀÇÇаú Ç¥Àû Ä¡·á°¡ Á߽õǰí, Ä¡·á °èȹ°ú ¸ð´ÏÅ͸µÀ» À§ÇØ Á¤È®ÇÑ ¼¼Æ÷ Á¤·®ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È­°¡ ÁøÇàµÊ¿¡ µû¶ó Ç÷±¸ °è¼ö ÀåÄ¡¿Í °Ë»ç Á¤º¸ °ü¸® ½Ã½ºÅÛ(LIMS)ÀÌ ÅëÇÕµÇ¾î ¿öÅ©Ç÷οì È¿À²¼º°ú µ¥ÀÌÅÍ Á¤È®¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¸¶Áö¸·À¸·Î, Ç÷±¸ °è¼ö ÀåÄ¡´Â ¼¼Æ÷ »ý¹°ÇÐÀÇ ±³À° ¹× ½ÇÇèÀ» ¼öÇàÇϱâÀ§ÇÑ ±âº» µµ±¸À̱⠶§¹®¿¡ ±³À° ±â°ü¿¡¼­ÀÇ ±³À° ¹× ¿¬±¸ ¸ñÀûÀ¸·ÎÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀ̵Ǿú½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñ 44»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hemocytometers Market to Reach US$2.9 Billion by 2030

The global market for Hemocytometers estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Reusable Hemocytometers, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Disposable Hemocytometers segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$421.6 Million While China is Forecast to Grow at 12.7% CAGR

The Hemocytometers market in the U.S. is estimated at US$421.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$601.3 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Hemocytometers Market - Key Drivers and Trends Summarized

Hemocytometers are precision instruments used for counting blood cells and other types of cells in a fluid sample. Typically, these devices consist of a thick glass microscope slide with a grid of precisely etched lines. When a sample is placed on the hemocytometer, the grid allows for an accurate count of cells under a microscope. Hemocytometers are essential in clinical diagnostics, research laboratories, and various fields of biotechnology for quantifying cell concentrations in blood, urine, and other biological fluids. The accurate counting of cells is crucial for diagnosing and monitoring diseases, conducting research, and developing pharmaceuticals.

The market for hemocytometers has evolved significantly due to advancements in technology and increasing applications in various scientific and medical fields. Modern hemocytometers now incorporate features that enhance accuracy and ease of use, such as improved grid designs and the use of durable, high-quality materials. Additionally, digital hemocytometers and automated cell counters have emerged, offering faster and more precise measurements, reducing human error, and increasing efficiency in laboratories. These innovations have broadened the application range of hemocytometers, making them indispensable tools in hematology, oncology, microbiology, and cell biology research. Moreover, the integration of hemocytometers with other diagnostic devices and software solutions has further streamlined cell counting processes and data management.

The growth in the hemocytometers market is driven by several factors. Firstly, the increasing prevalence of diseases that require regular blood cell monitoring, such as cancer and infectious diseases, has boosted the demand for hemocytometers. Secondly, the expansion of research and development activities in biotechnology and life sciences has spurred the need for accurate and reliable cell counting tools. Advances in digital and automated technologies have also played a significant role in market growth, as these innovations improve the accuracy and speed of cell counting. Additionally, the growing emphasis on personalized medicine and targeted therapies requires precise cell quantification for treatment planning and monitoring. The rise in laboratory automation and the integration of hemocytometers with laboratory information management systems (LIMS) have enhanced workflow efficiency and data accuracy. Lastly, the increasing adoption of hemocytometers in educational institutions for training and research purposes further drives market expansion, as they are fundamental tools for teaching and conducting experiments in cell biology.

Select Competitors (Total 44 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â